agent. IL-1 and IL-6 inhibitors have proven to be very helpful in the treatment of systemic JIA and MAS Glucocorticoids Glucocorticoids are conditionally recommended as part of initial treatment of systemic JIA with MAS. The benefits of glucocorticoids for MAS often outweigh their risks, even in patients whose MAS is triggered by infection. Systemic glucocorticoids may be necessary for severely ill patients because they can have a rapid onset of action. However, although treatment with